Pentucket Medical
   

SETH BILAZARIAN, MD, FACC, FAHA, FSCAI, FASNC, RPVI
Pentucket Medical - Haverhill
Cardiology

"I've been with Pentucket Medical since 1993, and it's been a really wonderful position for me. I get to practice in a community with very appreciative patients, and I'm able to collaborate with some outstanding physicians in a multi-specialty group."

   Play Video Message from Dr. Seth Bilazarian

   View patient story

   Watch Dr. Bilazarian on the local news

Dr. Seth Bilazarian, MD

Seth Bilazarian - Clinical Education/Certifications

Undergraduate
Tufts University
Medford, MA
Medical School
University of Massachusetts Medical School
Worcester, MA
Internship/Residency
 Johns Hopkins School of Medicine
Baltimore, MD
Fellowship
 University Hospital / Boston University School of Medicine
Boston, MA
Board Certifications
Internal Medicine
Cardiovascular Disease
Interventional Cardiology
Nuclear Cardiology
Vascular Medicine
Registered Physician in Vascular Interpretation

Fellow, American College of Chest Physicians, American College of Cardiology, and Society of Cardiac Angiography and Interventions

Contact Dr. Seth Bilazarian

To speak directly with Dr. Bilazarian's office, please call (978) 521-3288

Make an appointment

Inquire about referrals

Directions to Dr. Bilazarian's office

Dr. Bilazarian enjoys privileges with the following hospitals:
  • Merrimack Valley Hospital
  • Anna Jaques Hospital
  • Lawrence General Hospital
  • Holy Family Hospital
  • Whittier Rehabilitation Hospital

Dr. Seth Bilazarian - News, Information, Publications, Research

Dr. Seth Bilazarian leads Pentucket Medical's Cardiovascular Research Program. For more information on current enrolling trials, click here.

Instructor
Instructor of Medicine, Harvard Medical School

Articles
  • "Treatment Advances for Artery Blockages"
  • "Atrial Fibrillation"
  • "Metabolic Syndrome"
  • "Homocysteine"
  • "Intervention in Peripheral Vascular Disease" from The Journal of Invasive Cardiology

Dr. Bilazarian has also been published on a number of additional topics listed below. If you would like any additional information on any of these, please contact his office at (978) 521-3288.

  • Bilazarian. SD. Taylor, AJ; Brezinski, D; Hochberg, Me; Guarinier, T; Provost, TT; High grade atrioventricular heart block in adult RNP (Ul RNP) antibodies, a case report, and review of the literature. Arthritis & Rheumatism, 1989; 32:1170-1174.
  • Bilazarian, SD. Baughman, KL; Hutchins, DM; Hellman, DB. Systemic lupus erythematosus presenting as acute severe mitral regurgitation. American Journal of Medicine, 1990; 21: 103-5.
  • Bilazarian, SD. Shemin, RJ; Mills, RM. Catheterization of a graft from the descending aorta. Catheterization and Cardiovascular Diagnosis, 1990; 21: 103-5.
  • Bilazarian, SD. Pseudoinfarction pattern on electrocardiogram after coronary artery bypass. Chest, 1990; 98:1271-4.
  • Bilazarian, SD. Brush, JE. Drug therapy for chronic stable angina pectoris. P&T, 1991; 16:20029.
  • Bilazarian. SD. Jacobs, AK.; Fonger, JD; Faxon, DP. Case report of a coronary anomaly. Crossing Obtuse Margins. Catheterization and Cardiovascular Diagnosis, 1991; 23: 130-132.
  • Bilazarian, SD. Faxon, DP; Jacobs, AK.. Coronary sinus retroperfusion; a critical review. Coronary Artery Disease, 1991; 2:638-645.
  • Bilazarian, SD. Davidoff, R. Mitral regurgitation improves when aortic valve area increases significantly. (letter). American Journal of Cardiology, 1991; 68:567-8.
  • BiIazarian. SD. Mittal, S; Mills, RM. The extrarenal hazards of intravascular contrast material. Journal of Critical Illness, 1991; 6:859-869.
  • Podric, PJ, Bilazarian, SD. Fuch, TT. Prognostic importance of ventricular premature beats. Journal of Arrhythmia Management, Spring 1991; 32-48.
  • Dubrey, SW; Bilazarian. SD. LaValley, M; Reisinger, J; Skinner, M; Falk, RH. Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. American Heart Journal, 1997 December; 134 (6):994-1001.

Chapters

  • Podric, PJ; Bilazarian, SD. Fuch, IT. "Prognostic Importance of Ventricular Premature Beats" in Prognosis and Risk Assessment in Cardiovascular Disease, ed. Kapoor, AS; Singh, BN; Churchill Livingstone, New York, 1993.
  • Bilazarian. SD. Jacobs, AK. "Percutaneous Support Techniques" in Practical Angioplasty, ed. Faxon, DP, Raven Press, New York, 1994.

Abstracts

  • Bresee, SJ; Jacobs, AK.; Steenksite, A; Bilazarian, SD; Ruocco, NA; Detre, KM; Ryan, TJ; Faxon, DP; and Registry Investigators. Do coronaryrisk factors influence lesion morphology? A report from the 1985 - 1986 NHLBI PTCA Registry. Journal of the American College of Cardiology, 1990; 16:99A.
  • Bilazarian. SD; Currier, JW; Haudenschild, CC; Heyman, D; Powell, J; Ryan, TJ; Faxon, DP. Angiotensin converting enzyme inhibition reduces restenosis in experimental angioplasty. Joumal of the American College of Cardiology, 1990; 16:2268A.
  • Davidoff, R; Schoen, FJ; Ngoy, S; Bilazarian, SD; Apstein, CS. Angiotensin II rapidly induces L VH with asymmetric septal hypertrophy: An echo cardiographic-pathologic correlation.
  • Landau, C; Jacobs, AK; Currier, JW; Bilazarian, SD; Leitschuh, ML; Ryan, TJ; Faxon, DP. One year followup of PTCA induced dissections treated with a perfusion balloon catheter. Cire 1991; 84:11-130.
  • Bilazarian, SD; Mohammed A; Coats, M; Falk, RH. The signal-averaged electrocardiogram in amyloid heart disease. Journal of the American College of Cardiology. 1992; 19:324A.
  • Bilazarian, SD, Currier, JW; Kakuta, T; Haudenschild, CC; Faxon, DP. AngiotenSin II antagonism does not prevent after rabbit iliac angioplasty. Circ 1992; 86:1234.

Research
Dr. Seth Bilazarian has participated as collaborator/site investigator for many multicenter completed trials. To see a list of these trials, please click here. If you would like any additional information, please contact Dr. Bilazarian's office at (978) 521-3288.